- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
KalVista Pharmaceuticals (NASDAQ:KALV), Quotes and News Summary
KalVista Pharmaceuticals (NASDAQ: KALV)
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-09-08 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-07-12 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
KalVista Pharmaceuticals Questions & Answers
You can purchase shares of KalVista Pharmaceuticals (NASDAQ: KALV) through any online brokerage.
Other companies in KalVista Pharmaceuticals’s space includes: Molecular Partners (NASDAQ:MOLN), Outlook Therapeutics (NASDAQ:OTLK), AVEO Pharmaceuticals (NASDAQ:AVEO), Impel Pharmaceuticals (NASDAQ:IMPL) and Voyager Therapeutics (NASDAQ:VYGR).
The latest price target for KalVista Pharmaceuticals (NASDAQ: KALV) was reported by Stifel on Wednesday, June 8, 2022. The analyst firm set a price target for 32.00 expecting KALV to rise to within 12 months (a possible 218.09% upside). 3 analyst firms have reported ratings in the last year.
The stock price for KalVista Pharmaceuticals (NASDAQ: KALV) is $10.06 last updated June 27, 2022, 8:00 PM UTC.
There are no upcoming dividends for KalVista Pharmaceuticals.
KalVista Pharmaceuticals’s Q1 earnings are confirmed for Thursday, September 8, 2022.
There is no upcoming split for KalVista Pharmaceuticals.
KalVista Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.